Sinocare

Sinocare EBIT per Employee

The EBIT per Employee of Sinocare (300298.SZ) as of Oct 18, 2026 is 25,727.90 CNY. In the previous year, EBIT per Employee was 106,224.10 CNY — a change of -75.78% (lower).

EBIT per Employee

25,727.90CNY

YoY

-75.78%

Last updated:

EBIT per Employee of Sinocare is 2025 25,727.90 CNY. EBIT per Employee of Sinocare was 2024 106,224.10 CNY. It decreases by -75.78% lower compared to the previous year.

The Sinocare EBIT per Employee history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT per Employee
Date
EBIT per Employee
Jan 1, 2018
84,711.52 CNY
Jan 1, 2019
73,589.30 CNY
Jan 1, 2020
95,723.67 CNY
Jan 1, 2021
37,081.34 CNY
Jan 1, 2022
104,094.80 CNY
Jan 1, 2023
73,219.16 CNY
Jan 1, 2024
106,224.10 CNY
Jan 1, 2025
25,727.90 CNY
The Sinocare EBIT per Employee history
YEAREBIT per EmployeeYoY
25,727.90CNY-75.78%
106,224.10CNY+45.08%
73,219.16CNY-29.66%
104,094.80CNY+180.72%
37,081.34CNY-61.26%
95,723.67CNY+30.08%
73,589.30CNY-13.13%
84,711.52CNY+6.98%
79,186.81CNY+308.70%
19,375.16CNY-47.28%
36,748.39CNY-30.30%
52,724.04CNY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Sinocare Stock analysis

What does Sinocare do? Sinocare Inc, listed on the Shenzhen Stock Exchange under ticker 300298.SZ, operates as a healthcare company headquartered in Changsha, China. The company went public on March 19, 2012, and currently employs 3,756 full-time staff. Sinocare focuses on the development, production, and sale of rapid detection products for chronic diseases, particularly in the field of diabetes management. Its primary offerings include micro blood glucose monitoring systems, such as blood glucose testing devices and associated test strips, as well as mobile blood glucose monitoring instruments. The company also provides diabetes management information systems to support patient care and data tracking. Sinocare distributes its products both domestically within China and internationally under the brand name SANNUO. The company's website is https://www.sinocare.com/. Sinocare's business model centers on providing accessible and reliable diagnostic tools for chronic disease management, with a strong emphasis on diabetes-related products. The company operates within the healthcare sector, specifically targeting the health care industry segment. Its operations are based in Changsha, Hunan Province, and it serves both local and global markets through its branded products. Sinocare is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Sinocare stock

EBIT per Employee of Sinocare is 25,727.90 CNY in 2025.

EBIT per Employee of Sinocare changed from 106,224.10 CNY to 25,727.90 CNY, representing a -75.78% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBIT per Employee Sinocare since 2006 – with annual values, charts, and detailed analysis.

EBIT per employee measures operating profit per employee, showing how efficiently the workforce generates operating earnings.

EBIT per Employee's CNY is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBIT per Employee's Sinocare historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Workforce — Sinocare

All Key Metrics — Sinocare